Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania
Population pharmacokinetic/pharmacodynamic modeling (via NONMEM) was used to describe longitudinal exposure‐response relationships for total cariprazine (sum of cariprazine and its major active metabolites) in 2,558 patients with schizophrenia or bipolar mania. Drug exposure metrics were explored fo...
Saved in:
Main Authors: | Antonia Periclou (Author), Susan Willavize (Author), David Jaworowicz (Author), Julie Passarell (Author), Timothy Carrothers (Author), Parviz Ghahramani (Author), Suresh Durgam (Author), Willie Earley (Author), Margit Kapás (Author), Tatiana Khariton (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data
by: Stephen M. Stahl, et al.
Published: (2020) -
New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine
by: Werner FM, et al.
Published: (2015) -
Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)
by: Nakamura T, et al.
Published: (2016) -
Antidepressant Triggering Mania in Bipolar Disorder
by: Fatima Jahangir
Published: (2024) -
HOW ASSESS DRUGS IN THE TREATMENT OF ACUTE BIPOLAR MANIA ?
by: Michel eBourin, et al.
Published: (2013)